Diagnostic accuracy of a salivary polyamine-based cancer risk assessment test: an exploratory case-control study

Background SalivaChecker® assesses cancer risk based on salivary polyamine profiles. However, its ability to distinguish patients with established cancer from individuals without clinically significant abnormalities remains insufficiently characterized. This study evaluated the exploratory discrimination of SalivaChecker® in a selected exploratory case-control sample.Methods This exploratory case-control diagnostic-accuracy study included patients with established lung, pancreatic, gastric, colorectal, breast, or oral cancer who underwent perioperative oral management and apparently healthy individuals attending comprehensive health checkups. Saliva samples were collected under standardized morning fasting conditions and analyzed using SalivaChecker®. A positive result was defined as a high or very high risk classification for at least one of the six cancer types. Sensitivity and apparent specificity were estimated within the study sample.Results Among 101 participants, including 66 patients with cancer and 35 apparently healthy controls, SalivaChecker® was positive in 45 patients with cancer and 8 controls. The test-positive rate was higher in patients with cancer than in controls (45/66 [68.2%] vs 8/35 [22.9%]; unadjusted OR, 7.23; 95% CI, 2.81–18.58; Fisher’s exact test, p = 0.0000199). Clinically established cancer status remained associated with test positivity after adjustment for age and sex (adjusted OR, 4.861; 95% CI, 1.581–14.950; p = 0.006).Conclusion In this selected case-control sample, SalivaChecker® showed a moderate ability to distinguish patients with established cancer from apparently healthy controls. Because of the case-control design, spectrum bias, and differences in age between the groups, these estimates should not be extrapolated to asymptomatic screening populations or routine dental practice. Prospective studies in the intended-use population are required to determine screening performance and clinical utility.

Authors

Institutions

Publication Details

Journal
Future Science OA
Published
2026-11-18
DOI
https://doi.org/10.1080/20565623.2026.2758805
Primary Topic
Polyamine Metabolism and Applications
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Diagnostic accuracy of a salivary polyamine-based cancer risk assessment test: an exploratory case-control study

Shuji Nomoto, Masako Yoshimatsu, 照幸 新美, Takashi Ukai et al.
1 links
Future Science OA
Polyamine Metabolism and Applications
article

Diagnostic accuracy of a salivary polyamine-based cancer risk assessment test: an exploratory case-control study

Shuji Nomoto, Masako Yoshimatsu, 照幸 新美, Takashi Ukai, Hideto Imura, Nagato Natsume, Kayo Hayami, Sakiko Soutome, Motohiro Kurose, Masahiro Umeda
article en

Abstract

Background SalivaChecker® assesses cancer risk based on salivary polyamine profiles. However, its ability to distinguish patients with established cancer from individuals without clinically significant abnormalities remains insufficiently characterized. This study evaluated the exploratory discrimination of SalivaChecker® in a selected exploratory case-control sample.Methods This exploratory case-control diagnostic-accuracy study included patients with established lung, pancreatic, gastric, colorectal, breast, or oral cancer who underwent perioperative oral management and apparently healthy individuals attending comprehensive health checkups. Saliva samples were collected under standardized morning fasting conditions and analyzed using SalivaChecker®. A positive result was defined as a high or very high risk classification for at least one of the six cancer types. Sensitivity and apparent specificity were estimated within the study sample.Results Among 101 participants, including 66 patients with cancer and 35 apparently healthy controls, SalivaChecker® was positive in 45 patients with cancer and 8 controls. The test-positive rate was higher in patients with cancer than in controls (45/66 [68.2%] vs 8/35 [22.9%]; unadjusted OR, 7.23; 95% CI, 2.81–18.58; Fisher’s exact test, p = 0.0000199). Clinically established cancer status remained associated with test positivity after adjustment for age and sex (adjusted OR, 4.861; 95% CI, 1.581–14.950; p = 0.006).Conclusion In this selected case-control sample, SalivaChecker® showed a moderate ability to distinguish patients with established cancer from apparently healthy controls. Because of the case-control design, spectrum bias, and differences in age between the groups, these estimates should not be extrapolated to asymptomatic screening populations or routine dental practice. Prospective studies in the intended-use population are required to determine screening performance and clinical utility.

Future Science OAVol. 12(1)
Aichi Gakuin University (JP), Toyama University Hospital (JP), Nagasaki University Hospital (JP), University of Toyama (JP), Nagasaki University (JP)
Good health and well-being
Polyamine Metabolism and Applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon